Literature DB >> 6107135

Acebutolol, metoprolol and propranolol in conscious dogs with chronic heart-block: chronotropic effects and relation between depression of ventricular activity and beta-adrenoceptor blocking potency.

M Boucher, P Duchene-Marullaz.   

Abstract

1 Atrial and ventricular chronotropic effects of acebutolol, metoprolol and propranolol were studied in conscious dogs with chronic heart-block. Ventricular beta-adrenoceptor blocking activity was assessed for the three dogs against isoprenaline (1 microgram/kg) under the same experimental conditions. 2 Acebutolol and metoprolol significantly increased atrial rate. The effect was proportional to the dose for acebutolol, independent for metoprolol. Propranolol had no significant effect on atrial rate. All three drugs significantly lowered ventricular rate in proportion to the dose. 3 Ventricular beta-blocking potencies of metoprolol and acebutolol were respectively 2 and 3 times weaker than that of propranolol as indicated by ED50 values. 4 The ventricular depressor effect observed was proportional to the degree of ventricular beta-blockade present, although this may not be the only factor involved.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107135      PMCID: PMC2044333          DOI: 10.1111/j.1476-5381.1980.tb07941.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

1.  A comparison of the cardiovascular actions of four adrenergic -receptor blocking agents in resting, conscious dogs.

Authors:  M Bergamaschi; R G Shanks; A M Caravaggi; V Mandelli
Journal:  Am Heart J       Date:  1971-09       Impact factor: 4.749

2.  Analysis of the actions of alprenolol and propranolol on the beta adrenergic receptors controlling heart rate in the anaesthetized cat.

Authors:  B Ablad; A Brändström; L Ek; M Sjölander
Journal:  Eur J Pharmacol       Date:  1971-05       Impact factor: 4.432

3.  The assessment of -adrenoceptor blocking potency and cardioselectivity in vitro and in vivo.

Authors:  J R Baird; J Linnell
Journal:  J Pharm Pharmacol       Date:  1972-11       Impact factor: 3.765

4.  [Influence of yohimbine, phentolamine, D.C.I., pronethalol and propranolol on cardic frequency of the dog].

Authors:  P Duchêne-Marullaz; G Schaff; P Delort; J Billaud
Journal:  Therapie       Date:  1967 Nov-Dec       Impact factor: 2.070

5.  [Influence on the atrial rate of the dog in chronic atrioventricular block, of the atropine-propranolol combination and of excitation of the cardioaccelerating fibers of the vagus nerve].

Authors:  P Duch ene-Marullaz; A Combre; C Chassaing
Journal:  C R Seances Soc Biol Fil       Date:  1974

6.  Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog.

Authors:  L D Davis; J V Temte
Journal:  Circ Res       Date:  1968-05       Impact factor: 17.367

7.  On the sympathetic control of ventricular automaticity. The effects of stellate ganglion stimulation.

Authors:  M Vassalle; M J Levine; J H Stuckey
Journal:  Circ Res       Date:  1968-08       Impact factor: 17.367

8.  Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists.

Authors:  B Ablad; E Carlsson; L Ek
Journal:  Life Sci I       Date:  1973-02-01

9.  Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.

Authors:  M F Cuthbert; K Owusu-Ankomah
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

10.  Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

Authors:  B Basil; R Jordan; A H Loveless; D R Maxwell
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

View more
  10 in total

Review 1.  Efficacy and toxicity of antihypertensive pharmacotherapy relative to effective dose 50.

Authors:  Simon B Dimmitt; Hans G Stampfer; Jennifer H Martin; Robin E Ferner
Journal:  Br J Clin Pharmacol       Date:  2019-08-19       Impact factor: 4.335

Review 2.  Why maximum tolerated dose?

Authors:  Hans G Stampfer; Genevieve M Gabb; Simon B Dimmitt
Journal:  Br J Clin Pharmacol       Date:  2019-07-22       Impact factor: 4.335

3.  Mechanisms of chronotropic cardiac effects of alinidine and plasma concentration-response relationships in the conscious dog with chronic atrioventricular block.

Authors:  M Boucher; E Chapuy; M A Lefebvre; A Mignot; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

4.  Paradoxal pharmacologic effects observed with beta-blocker agents on cardiac cells in culture.

Authors:  N Moins; M Renoux; M Boucher; P Gachon
Journal:  In Vitro Cell Dev Biol       Date:  1991-02

Review 5.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

6.  Chronotropic effects of pindolol. Relation between ventricular effects and control resting ventricular rate values in conscious dogs with chronic A-V block.

Authors:  M Boucher; C Dubray; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-02       Impact factor: 3.000

7.  Dopamine in the conscious dog with chronic heart-block. Mechanisms of chronotropic cardiac effects.

Authors:  M Boucher; C Dubray; P Duchêne-Marullaz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

8.  Long-term observation of atrial and ventricular rates in the unanesthetized dog with complete atrioventricular block.

Authors:  M Boucher; C Dubray; P Duchene-Marullaz
Journal:  Pflugers Arch       Date:  1982-12       Impact factor: 3.657

9.  Chronotropic cardiac effects of histamine in the conscious dog with chronic atrioventricular block: interactions with the autonomic nervous system.

Authors:  J H Li; M Boucher; P Duchene-Marullaz
Journal:  Agents Actions       Date:  1986-11

10.  Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs.

Authors:  M Boucher; P Duchêne-Marullaz; J L Moundanga
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.